Dr Donald A Crawford, MD | |
1824 Memorial Dr, Clarksville, TN 37043 | |
(931) 552-6070 | |
(931) 552-9896 |
Full Name | Dr Donald A Crawford |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 1824 Memorial Dr, Clarksville, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144254384 | NPI | - | NPPES |
3012511 | Medicaid | TN | |
95153 | Other | TN | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 15767 (Tennessee) | Primary |
Entity Name | Clarksville Ob Gyn Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700956596 PECOS PAC ID: 7618871682 Enrollment ID: O20031121000160 |
News Archive
As U.S. President Barack Obama continues his official visit to Africa—with a stop Friday in Pretoria, South Africa to meet with President Jacob Zuma—advocates from AIDS Healthcare Foundation, the African Council of AIDS Service Organizations and South African AIDS patients will host a press conference in Pretoria, Friday, June 28th from 10:00am to 11:00am at the Sheraton Pretoria.
Deaths from ischemic heart disease and hypertensive diseases in the United States increased during the COVID-19 pandemic over the prior year, while globally, COVID-19 was associated with significant disruptions in cardiovascular disease testing.
In the study, the scientists screened known drugs and identified small molecules that could replace conventional reprogramming genes, which can have dangerous side effects.
Imagine a shiny new BMW sitting in your driveway. Now, imagine a shiny new Hyundai. Now, come up with one reason why you should drive that BMW. How about ten reasons? What about the Hyundai? A little bit harder isn't it?
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Donald A Crawford, MD 1824 Memorial Dr, Clarksville, TN 37043 Ph: (931) 552-6070 | Dr Donald A Crawford, MD 1824 Memorial Dr, Clarksville, TN 37043 Ph: (931) 552-6070 |
News Archive
As U.S. President Barack Obama continues his official visit to Africa—with a stop Friday in Pretoria, South Africa to meet with President Jacob Zuma—advocates from AIDS Healthcare Foundation, the African Council of AIDS Service Organizations and South African AIDS patients will host a press conference in Pretoria, Friday, June 28th from 10:00am to 11:00am at the Sheraton Pretoria.
Deaths from ischemic heart disease and hypertensive diseases in the United States increased during the COVID-19 pandemic over the prior year, while globally, COVID-19 was associated with significant disruptions in cardiovascular disease testing.
In the study, the scientists screened known drugs and identified small molecules that could replace conventional reprogramming genes, which can have dangerous side effects.
Imagine a shiny new BMW sitting in your driveway. Now, imagine a shiny new Hyundai. Now, come up with one reason why you should drive that BMW. How about ten reasons? What about the Hyundai? A little bit harder isn't it?
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
› Verified 9 days ago
Dr. Gary L Larkins, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1824 Memorial Dr, Clarksville, TN 37043 Phone: 931-552-6070 Fax: 931-552-9896 | |
Dr. Arif Mahood, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 104 Iris Court, Clarksville, TN 37042 Phone: 931-431-6670 Fax: 931-221-3400 | |
Audrey Hicks, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1824 Memorial Dr, Clarksville, TN 37043 Phone: 931-552-6070 Fax: 931-552-9896 | |
Dr. Jeffrey V Anderson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 490 Dunlop Ln, Clarksville, TN 37040 Phone: 931-245-8100 Fax: 931-245-8161 | |
Dr. William D Mcintosh, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2292 Dalton Dr, Suite C, Clarksville, TN 37043 Phone: 931-645-5595 Fax: 931-645-5596 | |
Mr. Stephen J Barton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1824 Memorial Dr, Clarksville, TN 37043 Phone: 931-552-6070 Fax: 931-552-9896 |